Inozyme Pharma
INZY
#8148
Rank
HK$1.49 B
Marketcap
HK$23.23
Share price
6.41%
Change (1 day)
-32.70%
Change (1 year)

EPS for Inozyme Pharma (INZY)

EPS in 2023 (TTM): -HK$12.15

According to Inozyme Pharma's latest financial reports the company's current EPS (TTM) is -HK$12.04. In 2022 the company made an earnings per share (EPS) of -HK$14.69 a decrease over its 2021 EPS that were of -HK$13.75.

EPS history for Inozyme Pharma from 2019 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$12.15-17.28%
2022-HK$14.696.78%
2021-HK$13.75-41.04%
2020-HK$23.33130.75%
2019-HK$10.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$16.94 40.65%๐Ÿ‡บ๐Ÿ‡ธ USA